title: Current advantage of FK 506 in cadaveric kidney transplantation.
authors.affiliation: Department of Surgery, University of Miami School of Medicine, Florida, USA.
authors.forename: G
authors.initials: G
authors.lastname: Ciancio
authors.forename: A
authors.initials: A
authors.lastname: Rosen
authors.forename: B
authors.initials: B
authors.lastname: Loreto-Grand
authors.forename: G
authors.initials: G
authors.lastname: Burke
authors.forename: A
authors.initials: A
authors.lastname: Siquijor
authors.forename: C
authors.initials: C
authors.lastname: Luque
authors.forename: V
authors.initials: V
authors.lastname: Esquenazi
authors.forename: J
authors.initials: J
authors.lastname: Miller
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002102:Cadaver; D016572:Cyclosporine / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000453:epidemiology; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015994:Incidence; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000473:pathology; D008775:Methylprednisolone / Q000627:therapeutic use; D010359:Patient Readmission; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use*; D014019:Tissue Donors
chemical_list: D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine; D016559:Tacrolimus; D008775:Methylprednisolone